Innovative Investment Models

Academic and Industry Intersection Conference

Thursday, April 30, 2015
9:00 a.m.-1:30 p.m.

Morehouse School of Medicine
Louis W. Sullivan National Center for Primary Care Auditorium
720 Westview Drive SW
Atlanta, GA 30310

Keynote Speaker

Pablo Legorreta, Royalty Pharma, Founder & CEO

Royalty Pharma recently bought drug rights on Vertex Pharmaceuticals’ cystic fibrosis treatments from the Cystic Fibrosis Foundation in a deal believed to be the largest financial return ever made by any charitable organization working to find cures for medical disease. The proceeds will lead to further CF research. Read More

What is the purpose?

The Atlanta Clinical & Translational Science Institute (ACTSI), led by Emory University with partners Morehouse School of Medicine and Georgia Institute of Technology, and Georgia Bio, the state's life sciences industry association, organizes this conference annually to provide critical information on how academia and industry can work together to translate science into discovery and engage communities in clinical research efforts and outcomes. The event provides a collaborative environment for university investigators and industry executives using a program filled with subject matter experts describing current models and innovative trends shaping the future of translational science.

What will be discussed?

The 6th Annual Academic & Industry Intersection Conference profiled successful public-private-partnerships as well as examined how to navigate the commercialization process, followed by an expert panel featuring stories of successful academic/industry partnerships and first-hand stories of commercializing new technologies and startup creation. The conference closed with a fast-paced Shark Tank featuring faculty, student, and industry innovators presenting their technologies to investors and successful bioscience entrepreneurs and executives.

Contact

Elizabeth Pittman Thompson

Upcoming Events

View All Events

Discovery News

Training

KL2 Scholar Studies Novel Hematopoietic Stem Cell Approach to Sickle Cell Disease Treatment

Elizabeth Stenger, MD, MSc, assistant professor, Department of Pediatrics, Emory University School of Medicine, received a K23 award for her work on improving haploidentical hematopoietic stem cell transplantation in sickle cell disease using...

Discovery

Research Resources 101: Using ACTSI's i2b2 Tool to Query Electronic Healthcare Records for Patient Study Feasibility Data-Thursday

The capabilities of Emory i2b2 will be discussed including how to query the Emory Healthcare electronic health record data for patient counts and aggregate data for grants/IRB protocols and other ways i2b2 can accelerate the pre-research process....